Cargando…
Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms
Drug-induced effects on cardiac contractility can be assessed through the measurement of the maximal rate of pressure increase in the left ventricle (LVdP/dt(max)) in conscious animals, and such studies are often conducted at the late stage of preclinical drug development. Detection of such effects...
Autores principales: | Guth, Brian D., Engwall, Michael, Eldridge, Sandy, Foley, C. Michael, Guo, Liang, Gintant, Gary, Koerner, John, Parish, Stanley T., Pierson, Jennifer B., Ribeiro, Alexandre J. S., Zabka, Tanja, Chaudhary, Khuram W., Kanda, Yasunari, Berridge, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697071/ https://www.ncbi.nlm.nih.gov/pubmed/31447679 http://dx.doi.org/10.3389/fphar.2019.00884 |
Ejemplares similares
-
Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
por: Ribeiro, Alexandre J. S., et al.
Publicado: (2019) -
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
por: Marei, Isra, et al.
Publicado: (2022) -
The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development
por: Kozak, Michael, et al.
Publicado: (2023) -
Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015) -
Cognitive performance outcomes: considerations for drug development
por: Zupan, Zorana
Publicado: (2023)